Supported by

Catalogue of collaboration profiles

back to list

Synthetic Nanomachines Ltd

Joseph Black Building, West Mains Road
ZIP Code
United Kingdom

Company Profile:
Synthetic Nanomachines Ltd is a specialty chemical synthesis company that specializes in the design, manufacture and supply of catenanes and rotaxanes – mechanically-interlocked molecules that can be designed and tailored to give stimuli-responsive properties.

Having its origins in the laboratory of Prof David Leigh FRS - a world leader in the design and construction of catenanes and rotaxanes and their application in artificial molecular motors and synthetic molecular machine systems - the spin-out company from the University of Edinburgh, supplies catenanes and rotaxanes to the new materials and life sciences R&D sectors.

Potential applications for catenane- or rotaxane-containing nanomachines range from advanced materials to novel drug delivery systems.

Rotaxane-based platform drug delivery system for peptide APIs

What we offer:
We design and synthesise molecules with mechanically-interlocked architectures that can be tailored to give stimuli-responsive properties - such as our platform drug delivery system that applies the rotaxane architecture to protect and selectively release a bioactive peptide drug molecule.

We provide a contract research service where we design and synthesize bespoke catenanes and/or rotaxanes to meet our clients' requirements: our clients identify the optimal properties needed for their application, and we design and synthesise the appropriate building blocks to produce the material with the desired properties and function.

What are we looking for:
We are looking for partnership opportunities - in the pharmaceutical, healthcare or specialty chemicals sectors - to exploit our knowhow and expertise in designing and synthesizing bespoke catenanes and rotaxanes for specific applications and commercialisation.

Collaboration sought:
  • Research & Development
  • Technical Co-operation
  • Joint Venture Agreement
  • Manufacturing Agreement
  • Commercial Agreement


Sau-Yin Sek

Managing Director
back to list


Enterprise Europe ScotlandAboleo LtdAccuro BiologicsAlliance BootsBeta TechnologyBitWiseFW Medical LLPInnova Partnerships LtdInterface-The knowledge connection for businessMarks and Clerk LLPMcClure Naismith LLPThe Medical Device Company LtdQuantics Consulting LtdScottish Health InnovationsPharmalinksSistemic LtdStrathclyde Institute of Medical DevicesSynthetic Nanomachines LtdTissue SolutionsUniversity of AberdeenEllis IP LtdPharmacells LtdCeltic CatalystsPharmaceutical eConsultingWeatherologyControlled TherapeuticsSphere Fluidics LimitedHighland Clinical Research FacilityMoorfields PharmaceuticalsEdinburgh Science Trianglebeocarta LtdRostiShore DesignPomBioTech GmbHIMG Innovations-Management  GmbH/ Enterprise Europe NetworkThe Eurotactics ConsultancyIBA GmbHSGS Life Science ServicesOnorach  ClinicalWideblueEnterprise Europe YorkshireAptuit ConsultingMosaigen/Endeavour CapitalEscubed LtdEulysis Ltd.Raumedic LtdCatalent Pharma SolutionsEscubed LtdUniversity of Aberdeen Research and InnovationSPRI - Basque Enterprise Europe NetworkLicentia LtdTake The WindRoslin CellabMoredun ScientificEnterprise Europe East of EnglandAvantiCell ScienceXeroshield Ltd.ImmunoSolv LimitedLeoben Research LimitedPRAXI / HELP-FORWARD Network &The Hellenic BioClusterEMBIO Diagnostics Ltd

© 2010 ConVerve GmbH | all rights reserved